{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:45:04Z","timestamp":1757706304478},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/maj.0b013e31825b2b50","type":"journal-article","created":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T08:47:47Z","timestamp":1351586867000},"page":"45-51","source":"Crossref","is-referenced-by-count":26,"title":["Cutaneous Vasculopathy and Neutropenia Associated With Levamisole-Adulterated Cocaine"],"prefix":"10.1016","volume":"345","author":[{"given":"Natasha Purai","family":"Arora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0192-0561(92)90179-O","article-title":"Levamisole, the story and the lessons","volume":"14","author":"Amery","year":"1992","journal-title":"Int J Immunopharmacol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0010","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/art.1780200801","article-title":"Treatment of rheumatoid arthritis with levamisole","volume":"20","author":"Runge","year":"1977","journal-title":"A controlled trial. Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0192-0561(79)90018-3","article-title":"Treatment of seronegative spondylarthritis with levamisole: a double-blind placebo-controlled study","volume":"1","author":"Christensen","year":"1979","journal-title":"Int J Immunopharmacol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0020","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0022-3476(80)80707-4","article-title":"Treatment of nephrotic syndrome with levamisole","volume":"96","author":"Tanphaichitr","year":"1980","journal-title":"J Pediatr"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0025","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/clpt.2010.156","article-title":"Levamisole: a dangerous new adulterant","volume":"88","author":"Chang","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0030","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2011.531","article-title":"Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital","volume":"305","author":"Buchanan","year":"2011","journal-title":"JAMA"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0035","first-page":"1381","article-title":"Agranulocytosis associated with cocaine use\u2014four States, March 2008-November 2009","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/bmj.1.6110.407","article-title":"Levamisole-induced vasculitis due to circulating immune complexes","volume":"1","author":"Macfarlane","year":"1978","journal-title":"Br Med J"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0045","author":"United States Department of Health and Human Services","year":"2008","journal-title":"National Survey on Drug Use and Health"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0050","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-152-11-201006010-00026","article-title":"Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole","volume":"152","author":"Bradford","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13181-010-0097-3","article-title":"Levamisole induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole","volume":"7","author":"Buchanan","year":"2011","journal-title":"J Med Toxicol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0060","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1600-0560.2010.01613.x","article-title":"Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole","volume":"37","author":"Walsh","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0065","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jaad.2010.01.055","article-title":"Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit?","volume":"63","author":"Waller","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0070","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/archdermatol.2010.335","article-title":"Levamisole-induced cutaneous necrosis mimicking coagulopathy","volume":"146","author":"Farhat","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0075","first-page":"217","article-title":"Levamisole-induced retiform purpura","volume":"10","author":"Click","year":"2011","journal-title":"J Drug Dermatol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5070\/D33Q1500T8","article-title":"Retiform purpura: a new stigmata of illicit drug use?","volume":"17","author":"Geller","year":"2011","journal-title":"Dermatol Online J"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0085","doi-asserted-by":"crossref","first-page":"E597","DOI":"10.1503\/cmaj.101005","article-title":"Reversible retiform purpura: a sign of cocaine use","volume":"183","author":"Han","year":"2011","journal-title":"CMAJ"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0090","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s10067-011-1805-3","article-title":"A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine","volume":"30","author":"Gross","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0095","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/BCR.0b013e318233fc64","article-title":"Levamisole-induced necrosis of skin, soft tissue, and bone: case report and review of literature","volume":"33","author":"Ching","year":"2012","journal-title":"J Burn Care Res"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0100","first-page":"1204","article-title":"Levamisole induced necrosis of the skin and neutropenia following intranasal cocaine use: a newly recognized syndrome","volume":"10","author":"Mouzakis","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/DAD.0b013e31821cc0bf","article-title":"Levamisole-induced vasculopathy: a report of 2 cases and a novel histopathologic finding","volume":"34","author":"Jacob","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0110","first-page":"307","article-title":"Images in emergency medicine","volume":"57","author":"Lung","year":"2011","journal-title":"Adult female with rash on lower extremities. Vasculopathic purpura and neutropenia caused by levamisole-contaminated cocaine. Ann Emerg Med"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/RHU.0b013e31821cb9d5","article-title":"A case of levamisole-induced systemic vasculitis and cocaine-induced midline destructive lesion: a case report","volume":"17","author":"Zwang","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/RHU.0b013e31820e6822","article-title":"Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine","volume":"17","author":"Ullrich","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0125","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jaad.2010.08.024","article-title":"Characteristic purpura of the ears, vasculitis, and neutropenia\u2014a potential public health epidemic associated with levamisole-adulterated cocaine","volume":"65","author":"Chung","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0130","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.jaad.2010.09.778","article-title":"ANCA-positive necrotizing vasculitis and thrombotic vasculopathy induced by levamisole-adulterated cocaine: a distinctive clinicopathologic presentation","volume":"65","author":"Jenkins","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0135","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MAJ.0b013e31822979f1","article-title":"Cocaine-induced thrombotic vasculopathy","volume":"342","author":"John","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0140","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/bmj.1.6110.408","article-title":"Cutaneous necrotising vasculitis induced by levamisole","volume":"1","author":"Scheinberg","year":"1978","journal-title":"BMJ"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0145","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3816\/CCC.2002.n.004","article-title":"Adjuvant therapy of colon cancer: a review","volume":"1","author":"Hobday","year":"2004","journal-title":"Clin Colorectal Cancer"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0155","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(77)92386-8","article-title":"Complications of cancer immunotherapy with levamisole","volume":"1","author":"Parkinson","year":"1977","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0160","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bmj.2.6086.555","article-title":"Levamisole-induced arthritis in Crohn\u2019s disease","volume":"2","author":"Segal","year":"1977","journal-title":"Br Med J"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0165","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/adc.75.4.355-b","article-title":"Vasculitis associated with levamisole and circulating autoantibodies","volume":"75","author":"Laux-End","year":"1996","journal-title":"Arch Dis Child"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0170","doi-asserted-by":"crossref","first-page":"287","DOI":"10.7326\/0003-4819-150-4-200902170-00102","article-title":"Agranulocytosis after consumption of cocaine adulterated with levamisole","volume":"150","author":"Zhu","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0175","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. Accessed January 8, 2012.http:\/\/oas.samhsa.gov\/nsduh\/2k9nsduh\/2k9resultsp.pdf"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0180","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4065\/80.5.671","article-title":"Cocaine-induced pseudovasculitis","volume":"80","author":"Friedman","year":"2005","journal-title":"Mayo Clin Pro"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0192-0561(91)90019-4","article-title":"On the biochemical mode of action of levamisole: an update","volume":"13","author":"Wauwe","year":"1991","journal-title":"Int J Immunopharmacol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2249.2007.03541.x","article-title":"Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells","volume":"151","author":"Chen","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1525-1470.1997.tb00695.x","article-title":"Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient","volume":"14","author":"Menni","year":"1997","journal-title":"Pediatr Dermatol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0200","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1046\/j.1365-2133.1999.02833.x","article-title":"Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children","volume":"140","author":"Rongioletti","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0205","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.0307-6938.2001.00944.x","article-title":"A boy with cutaneous necrosis occurring during treatment with levamisole","volume":"27","author":"Powell","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0210","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.semarthrit.2011.04.010","article-title":"Vasculopathy, hematological, and immune abnormalities associated with levamisole-contaminated cocaine use","volume":"41","author":"Khan","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e31825b2b50_bb0215","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.semarthrit.2011.05.009","article-title":"Syndrome of cocaine-levamisole-induced cutaneous vasculitis and immune-mediated leukopenia","volume":"41","author":"Poon","year":"2011","journal-title":"Semin Arthritis Rheum"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915307631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915307631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T17:32:46Z","timestamp":1643563966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915307631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0002962915307631"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e31825b2b50","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}